In 2014, Sanofi (NASDAQ:SNY) reached an agreement with Eli Lilly (NYSE:LLY) to buy exclusive rights to seek regulatory approval for Cialis OTC in countries including the U.S. when certain LLY ...
Opella, Sanofi’s Consumer Healthcare business, announced that the US Food and Drug Administration (FDA) has lifted a clinical hold on its planned actual use trial (AUT) to support the switch of Cialis ...